MIB2 and neoplasm: This is supported by our in vivo data demonstrating that loss of FAT1 as well as of MIB2 increased YAP/TAZ protein levels and tumor growth of Hela cells as well as of HNSCCs and that FAT1-mediated reduction in tumor progression depended on MIB2.